Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.51
-0.01 (-0.04%)
At close: Mar 19, 2026, 4:00 PM EDT
28.15
+0.64 (2.32%)
After-hours: Mar 19, 2026, 6:47 PM EDT

Assembly Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
72.328.527.16-6.25
Revenue Growth (YoY)
153.52%298.16%---92.09%
Gross Profit
72.328.527.16-6.25
Selling, General & Admin
19.6118.0122.9124.1328.78
Research & Development
64.8155.9348.969.9868.52
Other Operating Expenses
----41.64
Total Operating Expenses
84.4273.9471.8194.11138.94
Operating Income
-12.12-45.42-64.65-94.11-132.69
Interest Income
65.573.451.020.3
Total Non-Operating Income (Expense)
65.573.451.020.3
Pretax Income
-6.12-39.85-61.2-93.09-132.39
Provision for Income Taxes
-0.330.03-2.53
Net Income
-6.12-40.18-61.23-93.09-129.86
Net Income to Common
-6.12-40.18-61.23-93.09-129.86
Shares Outstanding (Basic)
116544
Shares Outstanding (Diluted)
116544
Shares Change (YoY)
86.71%31.18%13.47%11.85%22.17%
EPS (Basic)
-0.55-6.69-13.38-23.08-36.00
EPS (Diluted)
-0.55-6.69-13.38-23.08-36.00
Free Cash Flow
-41.16-51.1522.49-84.57-96.49
Free Cash Flow Per Share
-3.67-8.524.91-20.96-26.75
Gross Margin
100.00%100.00%100.00%-100.00%
Operating Margin
-16.76%-159.26%-902.50%--2121.65%
Profit Margin
-8.47%-140.87%-854.78%--2157.29%
FCF Margin
-56.93%-179.33%313.95%--1542.88%
EBITDA
-11.99-45.29-64.2-93.62-132.22
EBITDA Margin
-16.58%-158.80%-896.22%--2114.20%
EBIT
-12.12-45.42-64.65-94.11-132.69
EBIT Margin
-16.76%-159.26%-902.50%--2121.65%
Effective Tax Rate
0.00%-0.83%-0.05%0.00%-1.91%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q